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ABSTRACT
Background: Intake of caloric beverages is hypothesized to con-
tribute to adverse health outcomes, but the beverages and popula-
tions studied vary considerably.
Objective: Our objective was to examine the relation between
consumption of low- and whole-fat milk, fruit juice, and sugar-
sweetened beverages (SSBs) and cardiometabolic risk factors.
Design: We used data from a prospective 20-y cohort of 2774
adults. Data are taken from CARDIA (Coronary Artery Risk De-
velopment in Young Adults) Study examination years 0 (1985–
1986), 7 (1992–1993), and 20 (2005–2006). Beverage intake was
averaged across years 0 and 7, and continuous and categorical
(quartile) distributions were used. Incident (year 20) high waist
circumference (WC), high triglycerides, high LDL cholesterol,
low HDL cholesterol, hypertension, and metabolic syndrome were
examined by using multivariable-adjusted Poisson regression models.
Results: Higher SSB consumption (across quartiles) was associated
with higher risk of high WC [adjusted relative risk (aRR): 1.09;
95% CI: 1.04, 1.14; P for trend , 0.001]; high LDL cholesterol
(aRR: 1.18; 95% CI: 1.02, 1.35; P for trend = 0.018), high trigly-
cerides (aRR: 1.06; 95% CI: 1.01, 1.13; P for trend = 0.033), and
hypertension (aRR: 1.06; 95% CI: 1.01, 1.12; P for trend = 0.023).
Whole-fat milk consumption was associated with lower risk of high
triglycerides (aRR: 0.91; 95% CI: 0.81, 1.00; P for trend = 0.046).
With the use of continuous beverage intake, results were similar.
Consumers of whole-fat milk and SSBs were more likely to be
younger, black, and male and to have lower levels of physical
activity and higher total energy intake in comparison with noncon-
sumers (P , 0.05).
Conclusions: Our findings suggest that higher SSB consumption is
associated with cardiometabolic risk. Recommendations to limit
consumption of these caloric beverages may help reduce the burden
of these risk factors in US adult populations. Am J Clin Nutr
2010;92:954–9.
INTRODUCTION
In the past few decades in the United States, consumption of
beverages with calories has increased (1, 2), accounting for 21%
of daily total energy intake (2). Most of the focus has been on
sugar-sweetened beverages (SSBs). Consumption of SSBs is
linked with many adverse health outcomes as has been previously
shown in meta-analyses (3, 4).
The role of milk and dairy consumption on changes in weight
or the metabolic syndrome has been explored by using cross-
sectional (5) and longitudinal (6) study designs, with conflicting
results (7). Limited research has linked fruit juices with diabetes
(8, 9). Although associations between SSB consumption with
metabolic syndrome or type 2 diabetes were previously exam-
ined, these studies were of shorter duration, in woman only, or
excluded milk and fruit juice.
Given the dramatic trends in beverage consumption over the
past few decades (1), favoring energy-dense beverages with little
to no nutritional value, we sought to examine associations be-
tween intake of select beverages and continuous and categorical
incident cardiometabolic factors and the metabolic syndrome in
a sample of black and white young adults.
SUBJECTS AND METHODS
Study sample
The Coronary Artery Risk Development in Young Adults
(CARDIA) Study is a prospective study of cardiovascular risk
factors in 5115 persons aged 18–30 y at baseline examination
(1985–1986). Detailed description of recruitment procedures are
provided elsewhere (10). We used data from exam years 0 (1985–
1986, baseline), 7 (1992–1993), and 20 (2005–2006) in which
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dietary intake data were collected. We excluded women who
were pregnant at the time of interview (n = 75). Analysis pro-
cedures were in accordance with the ethical standards of the
University of North Carolina at Chapel Hill (UNC-CH), Gillings
School of Global Public Health, with UNC-CH Institutional
Review Board approval.
Exposure and outcome measures
Beverage intake
Dietary intake was assessed by using a semiquantitative,
interviewer-administered, validated (11) diet history food-
frequency questionnaire, which consisted of a short questionnaire
on general dietary practices followed by a comprehensive food-
frequency questionnaire, which asked about the previous month’s
consumption. We focused on low-fat (skim and 2% fat) and
whole-fat (3% fat) milk (consumed as a beverage, not used in
recipes), fruit juice, and sugar-sweetened soda and fruit drinks
(SSBs) as grouped by the CARDIA diet coordinating center. For
each beverage, baseline intake was defined as the average intake
from exam year 0 and 7 among persons with complete data.
Because diet soda does not provide calories, we do not examine
patterns of its consumption in this article. Furthermore, there is
a strong bimodal distribution of alcohol intake, and high, long-
term consumption represents a complex behavioral issue that is
outside the purview of this study. We examined 3 consumption
trends: energy per capita (estimates that account for persons who
did not consume the beverage), percentage consuming and en-
ergy per consumer (estimates that apply only to those in-
dividuals who reported consuming the beverage).
Anthropometric measurements, blood lipids, and metabolic
syndrome
Anthropometric measurements and blood lipid samples were
taken at each exam year (0, 7, and 20).Waist circumference (WC)
was measured as the average of 2 measures at the minimum
abdominal girth (nearest 0.5 cm) from participants standing
upright. HighWCwas defined asWC.88 cm (women) or.102 cm
(men).
Seated blood pressure [millimeters of mercury (mm Hg)] was
measured 3 times; we used the average of the last 2 measure-
ments. We excluded individuals who fasted for ,8 h Hyper-
tension was defined as systolic blood pressure (SBP) 130 mm
Hg, diastolic blood pressure (DBP) 85 mm Hg, or use of an-
tihypertensive medication.
Fasting blood samples were collected from which assays
determined lipids, glucose, and insulin according to standardized
CARDIA procedures (10). Briefly, fasting insulin and glucose
were obtained by venous blood draw, with glucose measured by
using hexokinase coupled to glucose-6-phosphate de-
hydrogenase. We created the following measures (which identify
adverse incident year 20 health outcomes) among persons
without prevalent outcome at year 0 or 7: high fasting glucose
6.1 mmol/L or use of diabetic medication; low HDL choles-
terol, defined as ,1.3 mmol/L in women or ,1.03 mmol/L in
men or use of cholesterol-lowering medication; high LDL
cholesterol, defined as 4.1 mmol/L or use of cholesterol-
lowering medication; and high triglyceride concentrations, defined
as 1.7 mmol/L or use of cholesterol-lowering medication.
Metabolic syndrome was defined according to Adult Treatment
Panel III guidelines (12) as being present if 3 of the following
factors were present at year 20 among those who did not have
metabolic syndrome at year 0 or 7: abdominal obesity, high
fasting glucose, low HDL cholesterol, hypertension, and/or high
triglycerides.
Covariates
Sociodemographic and selected health behavior covariates
included the following: race and sex, smoking status (classified as
never, former, or current), and highest education completed
(classified as less than high school, completed high school, or
more than high school). Physical activity was assessed by using
the CARDIA physical activity questionnaire, a validated and
reliable assessment of physical activity (13). A total score [ex-
ercise units (EU) per week] was computed by multiplying the
frequency of participation by the intensity of the activity. As an
example, a score of 100 EU is roughly equivalent to participation
in a vigorous physical activity 2 or 3 h/wk for 6 mo of the year,
calculated as [6 metabolic equivalent tasks (METs) · (3 · 6 mo
of high volume activity)]. A set of food groups measuring en-
ergy per day from meats, vegetables (except fried potatoes), fruit
(except fried fruit), and nonmilk dairy products was created
from the CARDIA diet history. Energy from food was calculated
by subtracting all beverage energy from total energy intake.
Statistical analysis
All analyses were conducted by using STATA (version 11.0;
Stata Corp, College Station, TX). We examined differences in
baseline sociodemographic covariates between consumers and
nonconsumers of whole-fat milk and SSBs by using 2-sided t
tests and chi-square tests for continuous and categorical varia-
bles, respectively. Within each of the 4 beverage groups, 2-sided
t tests (per capita and per consumer) and chi-square tests (per-
centage consuming) were also used to determine statistical
differences between years (with Bonferroni correction for mul-
tiple comparisons) for per capita/per consumer and percentage
consuming estimates, respectively.
To estimate the risk of incident year 20 outcomes, we used
separate multivariate Poisson regression models (n = 7 models)
of incident high WC (n = 2444), high fasting glucose (n = 2160),
high triglycerides (n = 2627), high LDL cholesterol (n = 2640),
low HDL cholesterol (n = 1837), hypertension (n = 2639), and
metabolic syndrome (n = 3596) on the 4 beverages of interest
(SSBs, fruit juice, low-fat milk, and whole-fat milk). All models
used beverages as continuous and divided in quartiles, which
allowed for tests of trend. Categorical results are presented here,
with continuous results shown under “Supplemental data” in the
online issue. We used robust estimators that allow the variance
of the error term to be dependent on our independent variables
(energy from beverages). Year 20 incidence models (ie, incident
high WC) were run by using individuals without prevalent
outcome (ie, high WC) at exam year 0 or 7.
Models were adjusted for race and sex as well as year 0 age,
weight, smoking status, total physical activity, calories from food,
calories from the other beverages, calories from alcohol, and
CARDIA exam center. Inclusion of a set of food groups (baseline
servings per day of meats, vegetables, fruit, and nonmilk dairy
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products) as opposed to total food calories did not affect results so
we included only the latter in the interest of building the most
parsimonious model possible (ie, the one with the fewest vari-
ables). Interactions with baseline overweight and race were tested
in multivariable linear models but were not statistically signifi-
cant (likelihood ratio test, P . 0.05). P value , 0.05 was set for
determining statistical significance in our continuous models.
RESULTS
Baseline (year 0) demographics are presented in Table 1.
Consumers of whole-fat milk and SSBs were significantly more
likely to be younger, black, male, and current smokers and to
have lower levels (EU/wk) of physical activity, higher total daily
energy intake, and higher SBP compared with nonconsumers
(P , 0.05). Consumers of SSBs were also more likely to have
lower levels of HDL cholesterol and higher diastolic blood
pressure compared with nonconsumers (Table 1). There were no
differences in any other anthropometric or blood lipid measure
between consumers and nonconsumers. Differences between
low-fat milk and fruit Juice consumers and nonconsumers are
available on request from the corresponding author.
Over 20 y, we observed a consistent increase in per capita
calories for SSBs, adjusted for age and sex, whereas per capita
intake of whole-fat and low-fat milk and fruit juice declined
(Table 2). There was a slight (7%) increase between year 0 and
year 7 followed by a considerable (14%) decrease between year
7 and year 20 in the percentage of the sample who consumed
low-fat milk. The percentage of the population consuming SSBs
steadily increased over the full time period, although only by
a small percentage, whereas the percentage consuming fruit
juice and whole-fat milk continuously declined. Energy per
consumer from low- and whole-fat milk experienced consistent
declines, whereas energy per consumer from SSBs increased
steadily over the 20 y (Table 2).
The most consistent adverse associations between beverage
intake and incident cardiometabolic outcomes were observed for
SSBs, in which higher (moving from one quartile to the next)
baseline consumption was associated with a significant increase
in the risk of incident high WC [adjusted relative risk (aRR):
1.09; 95% CI: 1.04, 1.14; P for trend, 0.001], high triglycerides
(aRR: 1.06; 95% CI: 1.01, 1.13; P for trend = 0.033), high LDL
cholesterol (aRR: 1.18; 95% CI: 1.02,1.36; P for trend = 0.018),
and hypertension (aRR: 1.06; 95% CI: 1.01, 1.12; P for trend =
0.023; Table 3). Associations for SSB intake were in the same
direction (associated with higher risk) for all other outcomes,
although these estimates were not statistically significant
(Table 3).
Moving from one quartile to the next of whole-fat milk and
fruit juice consumption was associated with lower risks of in-
cident high triglycerides (aRR: 0.91; 95% CI: 0.81, 1.00; P for
trend = 0.046) and hypertension (aRR: 0.89; 95% CI: 0.82, 0.97;
P for trend= 0.007), respectively. Consumption of low-fat milk
was not statistically significantly related to any incident car-
diometabolic risk factor or to the metabolic syndrome (Table 3).
Results using continuous beverage consumption were similar
with the major difference that SSB intake was significantly
associated with incident low HDL cholesterol (aRR: 1.06; 95%
CI: 1.02, 1.10; P , 0.05) and not hypertension or incident
high triglycerides, and fruit juice intake was not significantly
TABLE 1
Year 0 characteristics of study sample1
Variable
Year 0
(1985–1986)
Whole-fat milk SSBs
Consumer Nonconsumer Consumer Nonconsumer
n (%) 1865 (51.9) 1731 (48.1) 3425 (95.3) 171 (4.8)
Demographic characteristics
Female (%) 53.5 6 0.8 50.0 6 1.2 57.4 6 1.22 52.9 6 0.9 65.5 6 3.62
Black (%) 47.4 6 0.8 65.7 6 1.0 27.7 6 1.12 49.4 6 0.9 7.6 6 2.02
Age (y) 25.0 6 3.6 24.5 6 0.09 25.5 6 0.082 24.9 6 0.06 26.6 6 0.222
Smoking (%)
Current 28.1 6 0.8 32.9 6 1.1 23.1 6 1.02 28.6 6 0.8 18.7 6 3.02
Former 13.1 6 0.6 10.3 6 0.7 16.2 6 0.92 12.8 6 0.6 19.9 6 3.12
Never 58.7 6 0.8 56.8 6 1.1 60.7 6 1.22 58.6 6 0.8 61.4 6 3.7
Physical activity (EU/wk) 429 6 302 408.8 6 7.1 451.2 6 7.12 426.4 6 5.2 485.0 6 21.52
Energy from food (kcal) 2347 6 1373 2576.6 6 36.2 2100.5 6 25.92 2372.4 6 23.7 1847.0 6 70.92
Anthropometric and blood chemistry measurements
BMI (kg/m2) 24.5 6 5.0 24.2 6 0.11 24.3 6 0.11 24.3 6 0.08 23.8 6 0.3
Waist circumference (cm) 77.3 6 10.9 77.2 6 0.3 77.3 6 0.3 77.3 6 0.19 76.3 6 0.8
Glucose (mg/dL) 82.2 6 12.9 81.8 6 0.3 82.6 6 0.2 82.1 6 0.22 83.7 6 1.4
LDL cholesterol (mg/dL) 108.7 6 30.7 108.1 6 0.7 109.3 6 0.7 108.8 6 0.53 107.1 6 2.3
HDL cholesterol (mg/dL) 53.7 6 13.0 53.9 6 0.3 53.6 6 0.3 53.5 6 0.22 57.4 6 1.12
Triglycerides (mg/dL) 70.9 6 45.2 69.5 6 1.0 72.4 6 1.2 71.0 6 0.78 69.8 6 2.9
Blood pressure (mm Hg)
Systolic 110.3 6 10.9 111.0 6 0.3 109.6 6 0.32 110.5 6 0.2 107.6 6 0.92
Diastolic 68.6 6 9.6 68.5 6 0.2 68.6 6 0.2 68.6 6 0.2 67.3 6 0.82
1 Values are means 6 SDs or percentages 6 SEs unless otherwise indicated; n = 3596 (sample used to examine incident metabolic syndrome). SSBs,
sugar-sweetened beverages; EU, exercise units.
2 Estimates within beverage group (ie, SSB or whole-fat milk consumer compared with nonconsumer) are significantly different from one another, P ,
0.05 (chi-square test for dichotomous variables or Student’s t test for continuous variables).
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associated with any incident cardiometabolic outcome (see the
supplemental table under “Supplemental data” in the online
issue).
DISCUSSION
In this study we observed a significant increase in the risk of
incident high WC, triglycerides, LDL cholesterol, and incident
hypertension associated with greater consumption of SSBs
(moving across quartiles of intake). Higher baseline (average of
years 0 and 7) consumption of whole-fat milk and SSBs was also
associated with increased risk of several cardiometabolic risk
factors. Specifically, a 100-kcal higher baseline (average of years
0 and 7) consumption of SSBs (approximately one 8-ounce can)
or whole-fat milk (’6 ounces) was associated with a higher risk
of incident high WC, low HDL cholesterol (SSBs), and high
LDL cholesterol (SSBs and whole-fat milk) at year 20. Gener-
ally, associations with low-fat milk consumption and the health
outcomes of interest were in the same direction as SSBs but
failed to reach statistical significance.
TABLE 3
Estimated risk of incident cardiometabolic risk factors associated with baseline (quartile average of years 0 and 7) beverage intake1
Sample size
total
(outcome)
Beverage groups
LFM WFM FJ SSBs
RR
(95% CI)
P for
trend
RR
(95% CI)
P for
trend
RR
(95% CI) P for trend
RR
(95% CI)
P for
trend
High WC2 2444 (637) 1.02 (0.95,1.08) 0.639 1.06 (0.98,1.13) 0.143 1.00 (0.92,1.09) 0.999 1.09 (1.04,1.15) ,0.001
High fasting glucose3 2160 (267) 1.01 (0.90,1.13) 0.876 0.94 (0.83,1.07) 0.328 1.00 (0.88,1.14) 0.975 1.03 (0.95,1.12) 0.460
High TG4 2627 (542) 1.04 (0.96,1.11) 0.352 0.91 (0.83,1.00) 0.046 0.99 (0.91,1.09) 0.912 1.06 (1.01,1.13) 0.033
High LDL5 2640 (94) 1.07 (0.89,1.30) 0.475 1.10 (0.89,1.37) 0.400 0.96 (0.75,1.22) 0.741 1.18 (1.02,1.36) 0.018
Low HDL6 1837 (252) 1.01 (0.90,1.14) 0.826 0.96 (0.83,1.10) 0.539 1.00 (0.87,1.16) 0.927 1.06 (0.97,1.16) 0.192
Hypertension7 2639 (609) 0.98 (0.91,1.05) 0.539 1.01 (0.93,1.09) 0.810 0.89 (0.82,0.97) 0.007 1.06 (1.01,1.12) 0.023
Metabolic syndrome8 3596 (459) 1.00 (0.91,1.10) 0.980 0.91 (0.81,1.02) 0.094 0.98 (0.88,1.10) 0.779 1.03 (0.96,1.11) 0.401
1 Relative risk (RR) was estimated from multiple Poisson regression models (with robust SE estimator) of incident metabolic syndrome components and
incident metabolic syndrome according to quartile of beverage consumption (average of years 0 and 7), with adjustment for race (black or white), sex,
CARDIA (Coronary Artery Risk Development in Young Adults) exam center, and year 0 age, weight, smoking status [smoker, former smoker or never smoker
(referent)], energy from food, total physical activity, energy from the 3 other beverages, and energy from alcohol. Individuals with the outcome [ie, those with
a high waist circumference (WC)] at years 0 or 7 were excluded from analyses (ie, of incident year 20 high WC). LFM, low-fat milk; WFM, whole-fat milk;
FJ, fruit juice; SSBs, sugar-sweetened beverages; TG, triglycerides.
2 WC .102 cm [.40 inches (men)] or .88 cm [.35 inches (women)].
3 Fasting glucose 100 mg/dL (6.1 mmol/L) or use of diabetic medication.
4 TG 150 mg/dL (1.7 mmol/L) or use of cholesterol-lowering medication.
5 LDL 130 mg/dL or use of cholesterol-lowering medication.
6 HDL ,40 mg/dL [,1.04 mmol/L (men)], ,50 mg/dL [,1.3 mmol/L (women)], or use of cholesterol-lowering medication.
7 Blood pressure 130 mm Hg/85 mm Hg or use of antihypertensive medication.
8 Defined as having 3 of the following: 1) high fasting glucose, 2) high WC, 3) hypertension, 4) high TG, and 5) low HDL cholesterol.
TABLE 2
Age- and sex-adjusted per capita energy intake, percentage consuming, and per consumer energy intake of beverages1
Low-fat milk Whole-fat milk Fruit juice SSBs
n Values n Values n Values n Values
Per capita energy intake (kcal)
Year 0 5034 97 6 3 5034 100 6 3 5034 115 6 2 5034 167 6 3
Year 7 3877 97 6 5 3877 54 6 42 3877 114 6 92 3877 196 6 82
Year 20 3087 63 6 123,4 3087 33 6 83,4 3087 71 6 113,4 3087 218 6 243,4
Percentage consuming (%)
Year 0 5034 61 6 3 5034 47 6 3 5034 95 6 7 5034 89 6 5
Year 7 3877 68 6 85 3877 33 6 895 3877 93 6 145 3877 90 6 115
Year 20 3087 54 6 216,7 3087 26 6 286,7 3087 78 6 276,7 3087 91 6 256,7
Per consumer energy intake (kcal)
Year 0 3077 160 6 4 2356 204 6 6 4800 121 6 2 4443 188 6 3
Year 7 2760 143 6 72 1001 164 6 132 3623 122 6 102 3236 220 6 92
Year 20 1836 113 6 193,4 477 135 6 453,4 2551 87 6 133,4 2302 246 6 303,4
1 Values are means or percentages 6 SEs. Per capita energy intake estimates account for persons who did not consume the beverage. Per consumer
energy intake estimates apply only to those individuals who reported consuming the beverage. Sample sizes vary as stated. SSBs, sugar-sweetened beverages.
2,5 Significant difference between years 0 and 7, P , 0.05 (Bonferroni corrected): 2Student’s t test, 5chi-square test.
3,6 Significant difference between years 0 and 20, P , 0.05 (Bonferroni corrected): 3Student’s t test, 6chi-square test.
4,7 Significant difference between year 7 and 20, P , 0.05 (Bonferroni corrected): 4Student’s t test, 7chi-square test.
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Our research supports previous shorter-term studies in simi-
larly aged populations of a range of cardiometabolic measures
that have linked SSBs, fructose, and fruit drink consumption to
metabolic syndrome and type 2 diabetes (3, 14). It is interesting to
note in our findings that SSB consumption was associated with
several components of the metabolic syndrome but not with the
metabolic syndrome itself. These are findings that we cannot
fully explain, and except for a recent review by Malik et al (15),
which reports a systematic effect of SSBs on many car-
diometabolic components, the literature on overall metabolic
syndrome is quite slim.
Some (5, 16–20), but not all (6), studies have shown a bene-
ficial effect of dairy consumption on weight gain, metabolic
syndrome characteristics, and diabetes; however, most of these
studies examined total dairy intake and not dairy beverages
explicitly. In the CARDIA study population, increased total dairy
product consumption was inversely associated with a 10-y cu-
mulative risk of obesity, abnormal glucose homeostasis, elevated
blood pressure, and insulin resistance syndrome among over-
weight participants only (21).
In studies that examined milk specifically, results were con-
flicting (7). Among overweight adults, decreased consumption of
whole-fat milk was associated with decreased odds of 1 kg
weight gain over 8.8 y, whereas the opposite relation was ob-
served for those who increased their low-fat milk consumption
(22). By using follow-up through year 10 of the CARDIA data,
Pereira et al (21) reported that weekly consumption of milk
(combined low- and whole-fat) was associated with a statisti-
cally significant decrease in odds of elevated blood pressure, but
was unrelated to odds of dyslipidemia (21), only among over-
weight (body mass index; in kg/m2: 25) participants. Signifi-
cant differences in the present study related to exposures of
interest (whole- and low-fat milk beverages compared with total
dairy), time duration (13-y compared with 10-y incidence), and
choice of outcome (metabolic outcomes compared with insulin
resistance syndrome) may partially explain the observed dis-
parities between our study and theirs.
Several mechanisms may explain the higher risk observed
among those with higher SSB (continuous and categorical
results) or whole-fat milk consumption (continuous results only).
Increased consumption of added sweeteners, particularly high-
fructose corn syrup in SSBs, has been associated with increased
insulin resistance (23), reduced HDL cholesterol (24), visceral fat
(25), and increased triglyceride concentrations (26). Calcium and
magnesium from dairy products can affect lipid concentrations
through changing intestinal absorption of cholesterol, bile acids
and fats, and milk proteins (27), and the exchange of carbohy-
drate for protein intake may explain effects on serum profiles,
although results are conflicting (28, 29).
Compared with a nationally representative sample of US
adults, a considerably greater proportion of our sample reported
consuming each of the caloric beverages. For example, whereas
just over 50% of adults aged 19 yr (data from National Health
and Nutrition Examination Survey 2002) reported consuming
SSBs (1), a full 90% of our sample consumed these beverages,
a discrepancy that may be due to differences in the methods used
to ascertain dietary intake (two 24-h recalls compared with
a 1-mo FFQ). Also within our cohort we observed significant
age-related declines in SSB intake. Our CARDIA findings are
similar to national trends among older adults whereby older
individuals tend to reduce their intake of SSBs and diversify
their sources of liquid calories (30). Despite a greater proportion
of consumers, our per consumer estimates were considerably
lower than those observed in national studies (SSBs: 250 kcal;
low-fat milk: 223 kcal; fruit juice: 269 kcal; whole-fat milk:
240 kcal) (1).
Given the differences in consumption, it may be the case that
broad dietary patterns in individuals whomaintain high intakes of
caloric beverages account for some of the observed relation with
obesity and metabolic syndrome. Individuals with greater intake
of caloric beverages, and soda in particular, tend to have dietary
patterns characterized by greater intakes of total calories and
saturated and trans fats (31) and are at increased odds for
consuming snacks or high-fat foods and fast foods compared
with persons whose beverage patterns are dominated by water
consumption (2). The associations observed in this study, how-
ever, remained after control for total calories from foods and
inclusion of major food groups, suggesting an independent ef-
fect of the caloric beverages. This finding is supported by the
literature, which has shown a lack of dietary compensation when
caloric beverages are consumed (32, 33).
The major limitation of this study is that it is observational, and
we cannot rule out residual confounding nor can we draw
conclusive statements about the causal effect of caloric beverage
consumption on cardiometabolic risk. Measurement error in
dietary intake may result in nondifferential misclassification,
which would bias our estimates toward the null and lead to wider
CIs. Similarly, ascertainment of dietary data over the previous 30
d may not be enough to adequately capture habitual intake and, to
the extent to which this happens equally across subjects, could
also result in nondifferential misclassification. Finally, data on
exposure were collected 14 y before the measurement of our
outcome, and it is certainly possible that changes in beverage
consumption over this time period may affect the associations of
interest. Although our dietary intake information was self-
reported, we used a validated food-frequency questionnaire (11)
and averaged consumption information from 2 time points, which
should provide a better estimate of habitual intake than a single
estimate (34).
This study is one of the first to examine long-term intake of
caloric beverages, including both whole- and low-fat milk intake.
We observed consistent evidence of an association between
consumption of SSBs and incident cardiometabolic risk. These
results provide additional concerns about whole-fat milk intake in
addition to SSBs to our public health agenda.
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